BIT
MGNX icon

BlackRock Institutional Trust’s MacroGenics MGNX Stock Holding History

BlackRock Institutional Trust’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$16.6M Buy
814,004
+63,660
+8% +$1.6M ﹤0.01% 2097
2016
Q3 		$22.4M Buy
750,344
+29,937
+4% +$890K ﹤0.01% 1814
2016
Q2 		$19.4M Buy
720,407
+19,850
+3% +$448K ﹤0.01% 1865
2016
Q1 		$13.1M Sell
700,557
-144
-0% -$2.74K ﹤0.01% 2098
2015
Q4 		$21.7M Buy
700,701
+83,837
+14% +$2.55M ﹤0.01% 1808
2015
Q3 		$13.2M Buy
616,864
+258,733
+72% +$8.12M ﹤0.01% 2110
2015
Q2 		$13.6M Buy
358,131
+83,844
+31% +$2.76M ﹤0.01% 2192
2015
Q1 		$8.6M Buy
274,287
+13,686
+5% +$464K ﹤0.01% 2486
2014
Q4 		$9.14M Sell
260,601
-62,200
-19% -$1.55M ﹤0.01% 2416
2014
Q3 		$6.75M Buy
322,801
+40,850
+14% +$845K ﹤0.01% 2542
2014
Q2 		$6.13M Buy
281,951
+220,770
+361% +$4.64M ﹤0.01% 2686
2014
Q1 		$1.7M Buy
61,181
+10,614
+21% +$375K ﹤0.01% 3224
2013
Q4 		$1.39M Buy
+50,567
New +$1.32M ﹤0.01% 3292

Other funds holding MGNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BRC
Blue Ridge Capital New York $215M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

BlackRock Institutional Trust's MGNX Position: Q4 2016 in Review

BlackRock Institutional Trust increased its MacroGenics (MGNX) stake by 8.5% in Q4 2016, buying an estimated $1.6M and bringing the position to 814,004 shares worth $16.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2097.

BlackRock Institutional Trust first reported a position in MGNX in Q4 2013 and has held it in 13 quarters since. The position peaked at $22.4M in Q3 2016. 131 funds tracked by Wall St. Rank hold MGNX as of Q4 2016.

  • BlackRock Institutional Trust held 814,004 shares of MacroGenics worth $16.6M as of Q4 2016.
  • BlackRock Institutional Trust bought 63,660 MacroGenics shares in Q4 2016, an estimated $1.6M.
  • MacroGenics made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2097 holding.
  • BlackRock Institutional Trust first reported a position in MacroGenics in Q4 2013 and has held it in 13 quarters since.
  • BlackRock Institutional Trust's MacroGenics position peaked at $22.4M in Q3 2016.
  • 131 funds tracked by Wall St. Rank held MacroGenics as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.